Shaghouli, A., & Aranky, R. (2019). MON-LB032 Real World Evidence Data on the Role of Sodium/Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonist in Chronic Kidney Disease Stage 3 Patients beyond Glycemic Control, at Glycemia Clinic- Kuwait. J Endocr Soc.
Dyfyniad Arddull ChicagoShaghouli, Amna, and Rola Aranky. "MON-LB032 Real World Evidence Data On the Role of Sodium/Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonist in Chronic Kidney Disease Stage 3 Patients Beyond Glycemic Control, At Glycemia Clinic- Kuwait." J Endocr Soc 2019.
Dyfyniad MLAShaghouli, Amna, and Rola Aranky. "MON-LB032 Real World Evidence Data On the Role of Sodium/Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonist in Chronic Kidney Disease Stage 3 Patients Beyond Glycemic Control, At Glycemia Clinic- Kuwait." J Endocr Soc 2019.